Opioid receptor modulator dosage formulations | Patent Number 11311516

US 11311516 B2
Application Number17481874
Publication NumberUS 20220008394 A1
Pendency7 months, 6 days
Filled DateSep 22, 2021
Priority DateMar 14, 2013
Publication DateJan 13, 2022
Expiration DateMar 13, 2033
Inventor/ApplicantsPhilip Erna H. Heyns
Tim Costello
Philip Ema H. Heyns
Eugeen Maria Jozef Jans
Jens Jozef Ceulemans
ExaminesSTEVENS, MARK V
Art Unit1613
Technology Center1600
Assignments
Furiex Holdings Unlimited Company
Current
Allergan Holdings France S.a.s.Abbvie Inc.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.